Showing results (2401-2410 of 2,916) with videos related to

Sort By:
Pageof 292
Gynecologic Oncology|March 31, 2015
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Katherine Bell-McGuinn, et al.
Pilot and Feasibility Studies|August 7, 2025
North of England Women's Diet and ActivitY - After Breast Cancer (NEWDAY-ABC) intervention in women diagnosed with early oestrogen-positive, HER2-negative breast cancer: a randomised controlled feasibility studyC Wilson, K Pickering, S Wane, et al.
Stem Cell Reports|July 24, 2018
Optimal Hypoxia Regulates Human iPSC-Derived Liver Bud Differentiation through Intercellular TGFB SignalingHiroaki Ayabe, Takahisa Anada, Takuo Kamoya, et al.
The Biochemical Journal|July 25, 2015
A recycling pathway for cyanogenic glycosides evidenced by the comparative metabolic profiling in three cyanogenic plant speciesMartina Pičmanová, Elizabeth H Neilson, Mohammed S Motawia, et al.
Plos One|October 27, 2011
Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell linesShaija Samuel, Puja Gaur, Fan Fan, et al.
Annals of Surgical Oncology|May 24, 2015
Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast CarcinomaJames M Chang, Ann E McCullough, Amylou C Dueck, et al.
Journal of Medical Genetics|March 4, 2000
A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancerJ Gray, K Brain, P Norman, et al.
American Journal of Surgery|November 9, 2016
How does a concurrent diagnosis of cancer influence outcomes in emergency general surgery patients?Adil A Shah, Syed Nabeel Zafar, Awais Ashfaq, et al.
JAMA Internal Medicine|October 3, 2022
Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in ChildrenElizabeth A Suarez, Brian T Bateman, Sonia Hernández-Díaz, et al.
BMC Endocrine Disorders|July 27, 2019
Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional studyLaura J Gray, Emer M Brady, Olatz Albaina, et al.
Pageof 292